New Ultra-Low Temperature Freezer Offers Outstanding Sustainability and Sample Protection
A new ultra-low temperature freezer is designed to offer laboratories and biorepositories a greener solution: less power consumption, less noise and higher efficiency without compromising the integrity of samples.
The Thermo Scientific TSX ultra-low temperature freezer features natural refrigerants for lower environmental impact and higher cooling efficiency. Due to its intuitive design, the TSX freezer uses up to 50% less energy than conventional refrigerant ultra-low freezers and delivers temperature uniformity that continuously adapts to a laboratory’s environment.
“Energy efficiency is a feature most lab and biobank managers and sustainability officers look for when making purchasing decisions, but energy savings can come at the expense of sample integrity,” said Chris Champlin, vice president and general manager, Controlled Temperature Technologies at Thermo Fisher Scientific. “The new Thermo Scientific TSX ultra-low temperature freezer delivers unparalleled efficiency, noise reduction, and sample protection. Now, labs and biorepositories can not only reap the benefits of significant energy savings, but also feel confident that their samples are in an environment designed for their protection.”
Conventional ultra-low temperature freezers use single-speed compressors that continually cycle on and off, resulting in poor temperature recovery following door openings. The TSX ultra-low temperature freezer is the only freezer of its kind equipped with the unique V-Drive technology.
When conditions are stable, the V-Drive is designed to operate at a low speed to reduce energy consumption while maintaining a uniform temperature. When dealing with frequent door openings or when samples are added to the freezer, the control system detects the activity and increases the drive speed to bring temperatures quickly back to the set point.
The V-Drive also helps limit sound output to 46 db(A), making the TSX freezer up to 20 times quieter, comparable to a conventional refrigerator. For busy labs and biorepositories, the constant, disruptive noise created by compressors can compromise communications and create a less–than-ideal working environment. What’s more, the freezer utilizes water-blown foam insulation, which eliminates the off-gassing typical of urethane-insulated freezers.
Additional product features include a 600-box sample capacity to maximize storage within a 1.06-m2 footprint, intuitive touch screen interface for access to vital freezer information, and on-board computer and USB port for data storage and exchange.
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance